TEST:

OncoGuide™ NCC Oncopanel System

ABL1 (ABL proto-oncogene 1), AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ARAF (A-Raf Proto-Oncogene), ARID1A (AT-rich interaction domain 1A), ARID2 (AT-Rich Interaction Domain 2), ATM (ATM serine/threonine kinase), AXL (AXL Receptor Tyrosine Kinase), BAP1 (BRCA1 Associated Protein 1), BARD1 (BRCA1 Associated RING Domain 1), BCL2L11 (BCL2 Like 11), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), CCND1 (Cyclin D1), CDK4 (Cyclin-dependent kinase 4), CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), CHEK2 (Checkpoint kinase 2), CREBBP (CREB binding protein), CRKL (CRK Like Proto-Oncogene, Adaptor Protein), DDR2 (Discoidin domain receptor 2), EGFR (Epidermal growth factor receptor), ENO1 (Enolase 1), EP300 (E1A binding protein p300), ER (Estrogen receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), ERBB4 (erb-b2 receptor tyrosine kinase 4), EZH2 (Enhancer of zeste 2 polycomb repressive complex 2 subunit), FBXW7 (F-Box And WD Repeat Domain Containing 7), FGFR1 (Fibroblast growth factor receptor 1), FGFR2 (Fibroblast growth factor receptor 2), FGFR3 (Fibroblast growth factor receptor 3), FGFR4 (Fibroblast growth factor receptor 4), FLT3 (Fms-related tyrosine kinase 3), GNA11 (G Protein Subunit Alpha 11), GNAQ (G Protein Subunit Alpha Q), GNAS (GNAS Complex Locus), HER-2 (Human epidermal growth factor receptor 2), HRAS (Harvey rat sarcoma viral oncogene homolog), IDH1 (Isocitrate dehydrogenase (NADP(+)) 1), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2), IGF1R (Insulin-like growth factor 1 receptor), IGF2 (Insulin-like growth factor 2), IL7R (Interleukin 7 Receptor), JAK1 (Janus Kinase 1), JAK2 (Janus kinase 2), JAK3 (Janus Kinase 3), KDM6A (Lysine Demethylase 6A), KEAP1 (Kelch Like ECH Associated Protein 1), KIT (KIT proto-oncogene, receptor tyrosine kinase), KRAS (KRAS proto-oncogene GTPase), MAP2K1 (Mitogen-activated protein kinase kinase 1), MAP2K2 (Mitogen-activated protein kinase kinase 2), MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4), MDM2 (E3 ubiquitin protein ligase), MDM4 (The mouse double minute 4), MET (MET proto-oncogene, receptor tyrosine kinase), MLH1 (MutL homolog 1), MSH2 (MutS Homolog 2), MYC (V-myc avian myelocytomatosis viral oncogene homolog), MYCN (MYCN Proto-Oncogene BHLH Transcription Factor), NF1 (Neurofibromin 1), NFE2L2 (Nuclear Factor, Erythroid 2 Like 2), NOTCH1 (Notch 1), NOTCH2 (Notch 2), NOTCH3 (Notch Receptor 3), NRAS (Neuroblastoma RAS viral oncogene homolog), NRG1 (Neuregulin 1), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3), PALB2 (Partner and localizer of BRCA2), PBRM1 (Polybromo 1), PD-L1 (Programmed death ligand 1), PDGFRA (Platelet Derived Growth Factor Receptor Alpha), PDGFRB (Platelet Derived Growth Factor Receptor Beta), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1), PIK3R2 (Phosphoinositide-3-Kinase Regulatory Subunit 2 ), POLD1 (DNA Polymerase Delta 1), POLE (DNA Polymerase Epsilon), PTCH1 (Patched 1), PTEN (Phosphatase and tensin homolog), RAC1 (Rac Family Small GTPase 1), RAD51C (RAD51 paralog C), RAF1 (Raf-1 Proto-Oncogene Serine/Threonine Kinase), RB1 (RB Transcriptional Corepressor 1), RET (Ret Proto-Oncogene), RHOA (Ras homolog family member A), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), SETBP1 (SET Binding Protein 1), SETD2 (SET Domain Containing 2, Histone Lysine Methyltransferase), SMAD4 (SMAD family member 4), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4), SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1), SMO (Smoothened Frizzled Class Receptor), STAT3 (Signal Transducer And Activator Of Transcription 3), STK11 (Serine/threonine kinase 11), TMB (Tumor Mutational Burden), TP53 (Tumor protein P53), TSC1 (TSC complex subunit 1), VHL (von Hippel-Lindau tumor suppressor), mTOR (Mechanistic target of rapamycin kinase)